Matthew L. Posard - Jun 10, 2022 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
Director
Signature
/s/ J. Roger Moody, Jr., Attorney-in-Fact for Matthew L. Posard
Stock symbol
TLIS
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 05:41 PM
Previous filing
May 31, 2022
Next filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock Option (right to buy) Award $0 +95K $0.00 95K Jun 10, 2022 Common Stock 95K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date.